Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Neuroendocrine × irinotecan sucrosofate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 14 Colorectal Neoplasms 6 Small Cell Lung Carcinoma 4 Stomach Neoplasms 3 Neoplasm Metastasis 3 Biliary Tract Neoplasms 3 Recurrence 2 Nasopharyngeal Carcinoma 2 Cholangiocarcinoma 2 Triple Negative Breast Neoplasms 1 Somatostatinoma 1 Solid Tumor 1 Small Cell Lung Cancer Extensive Stage 1 Small Bowel Adenocarcinoma 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rectal Neoplasms 1 Pancreatic Cancer Non-resectable 1 Pancreatic Cancer Metastatic to Liver 1 Pancreatic Adenocarcinoma 1 PDAC - Pancreatic Ductal Adenocarcinoma 1 Neoplasms 1 Neoadjuvant Chemotherapy 1 Metastatic Pancreatic Adenocarcinoma 1 Locally Advanced Pancreatic Carcinoma(LAPC) 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Gastroesophageal Junction Adenocarcinoma 1 Gallbladder Neoplasms 1 Efficacy and Safety 1

Interventions

Everolimus 9 Cisplatin 7 Temozolomide 5 Bevacizumab 5 lutetium Lu 177 dotatate 4 Nivolumab 4 Etoposide 4 Carboplatin 4 Capecitabine 4 Irinotecan 3 sintilimab 2 pembrolizumab 2 dostarlimab 2 cabozantinib 2 azaspirane 2 avelumab 2 atezolizumab 2 Paclitaxel 2 Ipilimumab 2 Immunoglobulin G 2 IFL protocol 2 Fluorouracil 2 Fluorodeoxyglucose F18 2 Disulfides 2 zimberelimab 1 surufatinib 1 selinexor 1 pertuzumab 1 pasireotide 1 niraparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03837977 2024-12-30

NET02

The Christie NHS Foundation Trust

Phase 2 Completed

Neoplasms, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡